An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Clinical trial NCT01134666 · TERMINATED
Trial details
- NCT number
- NCT01134666
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2009-11-30
- Primary completion
- 2013-07-31
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.